Published in J Clin Invest on March 01, 1988
Identification of transcripts encoding a parathyroid hormone-like peptide in messenger RNAs from a variety of human and animal tumors associated with humoral hypercalcemia of malignancy. J Clin Invest (1988) 1.06
Production of parathyroid hormone-related protein in tumour xenografts in nude mice presenting with hypercalcaemia. Br J Cancer (1991) 0.76
Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med (1979) 3.43
The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms. N Engl J Med (1984) 2.33
Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells. J Clin Invest (1983) 1.84
Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors. J Clin Invest (1983) 1.77
Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy. Proc Natl Acad Sci U S A (1983) 1.75
Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. J Clin Endocrinol Metab (1982) 1.68
Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy. Science (1983) 1.52
APPLICATION OF ATOMIC ABSORPTION SPECTROPHOTOMETRY IN THE DETERMINATION OF CALCIUM IN SERUM. Clin Chem (1964) 1.41
Absence of parathyroid hormone messenger RNA in nonparathyroid tumors associated with hypercalcemia. N Engl J Med (1983) 1.27
Frequency and partial characterization of adenylate cyclase-stimulating activity in tumors associated with humoral hypercalcemia of malignancy. J Bone Miner Res (1986) 0.97
Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721. J Clin Invest (1986) 0.85
Parathyroid hormone-like changes in renal calcium and phosphate reabsorption induced by Leydig cell tumor in thyroparathyroidectomized rats. Endocrinology (1986) 0.84
Pathogenesis of hypercalcemia in nude mice bearing a human renal carcinoma. Endocrinology (1986) 0.81
Renal-cell carcinoma. N Engl J Med (1996) 11.46
Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat Genet (1999) 4.23
Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res (1999) 3.58
Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med (1980) 3.15
Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med (1990) 2.76
Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res (1997) 2.72
Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci U S A (1996) 2.53
Tumor therapy with targeted atomic nanogenerators. Science (2001) 2.48
Constitutive and antibody-induced internalization of prostate-specific membrane antigen. Cancer Res (1998) 2.38
Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem (1987) 2.30
Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. Proc Natl Acad Sci U S A (1988) 2.20
Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man. J Clin Invest (1970) 2.18
Clonal rat parathyroid cell line expresses a parathyroid hormone-related peptide but not parathyroid hormone itself. Biochem Biophys Res Commun (1989) 2.15
Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer (1999) 1.91
Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev (1996) 1.91
In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. Cancer Res (2000) 1.91
Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J Cell Biol (1997) 1.87
Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man. J Clin Invest (1970) 1.86
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer. Cancer Res (2000) 1.85
Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells. J Clin Invest (1983) 1.84
Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide. N Engl J Med (1988) 1.82
Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy. Proc Natl Acad Sci U S A (1983) 1.75
Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen. Neoplasia (1999) 1.74
Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med (1982) 1.71
Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. J Clin Endocrinol Metab (1982) 1.68
Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility. Mol Biol Cell (2001) 1.68
Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development. Development (1998) 1.64
Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res (1990) 1.53
Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus. Arch Virol (1989) 1.53
Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man. J Clin Invest (1972) 1.52
N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains. Biochem Biophys Res Commun (1987) 1.51
Effects of glucagon on adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in human plasma and urine. J Clin Invest (1970) 1.49
Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein. Annu Rev Med (1994) 1.49
Bone densities in patients receiving isotretinoin for cystic acne. Arch Dermatol (1999) 1.48
Nephrogenous cyclic adenosine monophosphate as a parathyroid function test. J Clin Invest (1977) 1.47
Overexpression of parathyroid hormone-related protein in the skin of transgenic mice interferes with hair follicle development. Proc Natl Acad Sci U S A (1994) 1.42
Analysis of adenosine 3',5'-monophosphate with luciferase luminescence. Anal Biochem (1970) 1.40
Simultaneous pulmonary and renal malignancy. Chest (1990) 1.39
Cryptosporidium in snakes with hypertrophic gastritis. Vet Pathol (1977) 1.35
Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250. J Clin Oncol (1993) 1.35
Cross-cultural association between dietary animal protein and hip fracture: a hypothesis. Calcif Tissue Int (1992) 1.34
Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer (1993) 1.31
Isolation and characterization of the human parathyroid hormone-like peptide gene. Proc Natl Acad Sci U S A (1989) 1.31
Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med (1984) 1.29
Elevations in circulating 1,25-dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia. J Clin Endocrinol Metab (1985) 1.29
Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. Development (1995) 1.26
Malignancy-associated hypercalcemia: evaluation with a cytochemical bioassay for parathyroid hormone. J Clin Endocrinol Metab (1981) 1.24
Murine gammaherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-gamma receptor knockout mice. Am J Pathol (2001) 1.23
Increased circulating concentrations of parathyroid hormone in healthy, young women consuming a protein-restricted diet. Am J Clin Nutr (1997) 1.22
Dietary protein affects intestinal calcium absorption. Am J Clin Nutr (1998) 1.21
Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma. Cancer Res (1997) 1.21
Serum parathyroid hormone level is elevated in some patients with disorders of keratinization. Arch Dermatol (1992) 1.19
Intrauterine occupancy controls expression of the parathyroid hormone-related peptide gene in preterm rat myometrium. Proc Natl Acad Sci U S A (1990) 1.18
Expression of messenger ribonucleic acids encoding a parathyroid hormone-like peptide in normal human and animal tissues with abnormal expression in human parathyroid adenomas. Mol Endocrinol (1988) 1.18
Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A. Proc Natl Acad Sci U S A (1993) 1.16
Reduced expression of beta-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma. J Urol (1999) 1.15
Immunoanatomic dissection of the human urinary tract by monoclonal antibodies. J Histochem Cytochem (1984) 1.15
Metabolic basis of renal-stone disease. N Engl J Med (1979) 1.15
Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats. J Clin Invest (1988) 1.14
Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer. Proc Natl Acad Sci U S A (1985) 1.14
Immunoanatomic distribution of cytostructural and tissue-associated antigens in the human urinary tract. Am J Pathol (1987) 1.12
Analysis of a novel strain of murine gammaherpesvirus reveals a genomic locus important for acute pathogenesis. J Virol (2001) 1.11
Spontaneous wasting disease in nude mice associated with Pneumocystis carinii infection. Lab Anim Sci (1986) 1.11
Sendai virus infection in genetically resistant and susceptible mice. Am J Pathol (1981) 1.10
Pregnancy as state of physiologic absorptive hypercalciuria. Am J Med (1986) 1.10
A parathyroid hormone-like protein from cultured human keratinocytes. Science (1986) 1.09
Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Clin Cancer Res (1999) 1.09
Experimental Lyme disease in rabbits: spirochetes found in erythema migrans and blood. Infect Immun (1984) 1.08
The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism. N Engl J Med (1980) 1.08
Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups. J Clin Endocrinol Metab (1978) 1.08
Macrophage colony-stimulating factor release and receptor expression in bone cells. J Bone Miner Res (1993) 1.07
Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma. Clin Cancer Res (1998) 1.07
Changes in bone turnover in young women consuming different levels of dietary protein. J Clin Endocrinol Metab (1999) 1.06
Identification of transcripts encoding a parathyroid hormone-like peptide in messenger RNAs from a variety of human and animal tumors associated with humoral hypercalcemia of malignancy. J Clin Invest (1988) 1.06
Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice. Clin Cancer Res (1998) 1.06
Long-term treatment of familial hypophosphatemic rickets with oral phosphate and 1 alpha-hydroxyvitamin D3. J Pediatr (1981) 1.06
Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591). Cancer Res (2001) 1.04
Recurrent hyperparathyroidism from an autotransplanted parathyroid adenoma. N Engl J Med (1978) 1.04
Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia. J Clin Endocrinol Metab (1994) 1.04
Dual infection with Pneumocystis carinii and Pasteurella pneumotropica in B cell-deficient mice: diagnosis and therapy. Comp Med (2000) 1.03
Humoral hypercalcemia of malignancy in canine lymphosarcoma. Endocrinology (1988) 1.01
Infection in rabbits with the Lyme disease spirochete. Yale J Biol Med (1985) 1.01
Extracellular cyclic nucleotides. Ann N Y Acad Sci (1971) 1.01
Parathyroid hormone-related protein: from hypercalcemia of malignancy to developmental regulatory molecule. Am J Med Sci (1996) 1.01
Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein. J Bone Miner Res (1996) 0.99
The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9. Cancer (1999) 0.99
Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancers. Cancer Metastasis Rev (1999) 0.99
The cell-surface form of colony-stimulating factor-1 is regulated by osteotropic agents and supports formation of multinucleated osteoclast-like cells. J Biol Chem (1998) 0.99
Structure of the mouse gene encoding parathyroid hormone-related peptide. Gene (1990) 0.98
Mice with skin-specific DNA repair gene (Ercc1) inactivation are hypersensitive to ultraviolet irradiation-induced skin cancer and show more rapid actinic progression. Oncogene (2006) 0.98